Literature DB >> 19322005

Penile vascular impairment in erectile dysfunction patients with metabolic syndrome: penile Doppler ultrasound findings.

Omer Demir1, Tevfik Demir, Aykut Kefi, Mustafa Secil, Abdurrahman Comlekci, Sena Yesil, Ahmet Adil Esen.   

Abstract

BACKGROUND: The constellation of truncal obesity, glucose intolerance, dyslipidemia (high triglycerides, low HDL cholesterol), and hypertension has been recognized as metabolic syndrome. However, the pathophysiological association between metabolic syndrome and erectile dysfunction (ED) has not yet been clearly determined. This study aimed to evaluate the penile Doppler ultrasound (PDU) findings of ED patients with metabolic syndrome. PATIENTS AND METHODS: Sixty-one age-matched ED patients with or without metabolic syndrome were included in the study. Patients were investigated by grouping according to risk factors of metabolic syndrome with PDU parameters (5th, 10th and 20th minute peak systolic velocity and end-diastolic velocity). PDU parameters of patients with and without metabolic syndrome were compared.
RESULTS: The mean age of the patients were 54.9 +/- 8.3 and 54.9 +/- 7.6 years for the groups of with (n = 27) and without (n = 34) metabolic syndrome, respectively. When the mean peak flow velocities were compared with presence of metabolic syndrome, we observed differences between at the 5th, 10th and 20th minute peak systolic velocities (p = 0.083, p = 0.022 and p = 0.080, respectively).
CONCLUSION: Metabolic syndrome seems to be the potential risk factor for ED, which may exert its effect by decreased arterial inflow due to endothelial dysfunction. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19322005     DOI: 10.1159/000200795

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

1.  Are vascular disorders a common cause of erectile dysfunction in non hypogonadal, non neuropsychiatric patients?

Authors:  I Vakalopoulos; P Thanos; G Gkotsos; D Radopoulos
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

2.  Metabolic syndrome and erectile dysfunction: the ultrasound evaluation of cavernosal atherosclerosis.

Authors:  Mirko Schipilliti; Nicola Caretta; Pierfrancesco Palego; Riccardo Selice; Alberto Ferlin; Carlo Foresta
Journal:  Diabetes Care       Date:  2011-07-05       Impact factor: 19.112

3.  The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction.

Authors:  Xu-Jun Xuan; Gang Bai; Cai-Xia Zhang; Chao Xu; Fu-Ding Lu; Yang Peng; Gang Ma; Cong-Hui Han; Jun Chen
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

4.  Changes in Erectile Function after Photoselective Vaporization of the Prostate with a 120-W GreenLight High-Performance System Laser: 2-Year Follow-Up.

Authors:  Juhyun Park; Sung Yong Cho; Min Chul Cho; Hyeon Jeong; Hwancheol Son
Journal:  World J Mens Health       Date:  2017-11-16       Impact factor: 5.400

Review 5.  Metabolic diseases affect male reproduction and induce signatures in gametes that may compromise the offspring health.

Authors:  Sara C Pereira; Luís Crisóstomo; Mário Sousa; Pedro F Oliveira; Marco G Alves
Journal:  Environ Epigenet       Date:  2020-12-08

6.  HoLEP does not affect the overall sexual function of BPH patients: a prospective study.

Authors:  Sung Han Kim; Hyung-Kook Yang; Hahn-Ey Lee; Jae-Seung Paick; Seung-June Oh
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.